We are living through a shift that almost no one is talking about, yet every family feels. Illness today doesn’t look like illness twenty years ago. It doesn’t behave the same, it doesn’t follow the same patterns, and it doesn’t respect the boundaries we used to believe existed. Babies are facing conditions once seen only in adults. Adults are developing diseases once considered rare. Older adults are navigating treatment plans so complex they rival hospital protocols. And fa

Some moments stay with you long after the hospital lights fade. Counting Ceiling Tiles was born in those hours — the quiet, heavy ones where you’re lying awake, trying to make sense of your own body, your future, and the uncertainty that keeps reshaping your life. Anyone who has lived through rare, chronic, or mitochondrial‑driven conditions knows those nights. They’re not dramatic. They’re not loud. They’re the moments where you learn how strong you are simply by getting thr

Innovation rarely begins in the places we expect. It doesn’t start in boardrooms, clinical offices, or corporate strategy decks. It starts in the quiet moments — the late‑night clarity, the lived experience, the questions people carry but rarely say out loud. Ideas begin in the margins of life, long before they become products, protocols, or companies. And the truth is simple: no one brings an idea to life alone. Corporations play a role. Clinicians play a role. Patients and

There are more than 10,000 known rare diseases affecting over 30 million people in the United States—about one in every ten people. About half of them are children. Most of these conditions are serious or life‑threatening, and only around 5–10% have an FDA‑approved treatment. Families spend their lives managing what medicine still hasn’t fully caught up to, stitching together care in the space between appointments, between crises, between answers. MediXo is being built for th

Health isn’t a single‑month conversation, and it isn’t owned by any one group. Men’s Health Month matters. Women’s Health matters. Rare and complex disease communities matter. And so do the people who are healthy today and working to stay that way. When you step back, you realize all of these moments are connected by one truth: every person is carrying a story about their body, their wellbeing, their fears, their hopes, and their future. A brand that claims to care about heal

Founder Michael Goldberg reflects on urgency, innovation, and the lived experience that drives MediXo By 12 Brand. Last week, I spoke from lived experience. This week, I want to show what that experience builds. At MediXo By 12 Brand, we don’t just talk about urgency—we engineer for it. Axis and Go aren’t concepts. They’re responses. To delay. To fragility. To the silence that too often surrounds rare disease and complex illness. Every module, every advisor, every visual asse

The Quiet Revolution: How Connected Medical Devices Are Becoming Lifelines for Rare Disease and Complex Illness Communities We've spent countless mornings immersed in our own health tracking rituals. The meticulous logging, the careful documentation—not because we wanted to, but because complex illness demands it. When you're living this reality, tracking isn't optional. It's survival. Here's what keeps me up at night: millions of us are generating vital health data every sin